Live agbiotech updates

Live agbiotech news coverage of developments with the latest updates. Stay on top of latest agbiotech news stories and find out what just happened, what is going on with agbiotech. The latest real-time news updates and headlines on agbiotech
AnteoTech’s updated Covid RAT receives regulatory approval in Europe
FDA confirms diagnostic method for Medibio’s final depression validation trial
Illumina’s Susan Tousi on genomics and changing healthcare
PharmAust says MPL tablets arrive for Motor Neuron Disease trial
Nyrada says European patent to be granted for cholesterol-lowering drug
Help AusBiotech 2022 programme ‘Come Alive’
Immuron partner submits IND application to US FDA for new therapeutic
NeuroScientific Biopharmaceuticals submits for approval of early-phase trial
Industry-backed plan to navigate Australian biotech into future
Prescient expands PTX-200 AML cohort following additional complete remission
NSW Government launches 20-year roadmap for industry
Botanix acquires rights to new dermatology product
New senior appointments for Tessara Therapeutics
Biotron says BIT225 against SARS-CoV-2 infection effective in animals
INOViQ announces manufacturing agreement with MP Biomedicals
Cochlear agrees to acquire Oticon Medical
First subjects randomised and dosed in Paradigm’s late-stage trial
Adherium releases next generation respiratory platform integration services
Opthea announces appointment of two new directors
New UK-based business development for Adherium
NSW Government seeks operator for RNA manufacturing
Medlab Clinical confirms northern hemisphere distribution
Volpara Health announces leadership and board changes
Mission to BioKorea to strengthen ties
EpiAxis Therapeutics appoints new chief science officer
Zelria Therapeutics executes acquisition of Health House
Botanix confirms presentation of data at upcoming congress
Imugene says first cohort two patient dose in phase 1 clinical trial
Microbio is step closer to launching its InfectID-BSI tests in Europe
Rhonomed completes institutional component of capital raise
Australian Pavilion returns in-person to BIO 2022
MTPConnect announces support for major new resilience projects
Race receives human ethics approval for new trial
Microba announces new research partnership and senior appointment
Australian healthcare investor urges greater support from peers
Avecho reports positive results for Phase 2 topical CBD osteoarthritis study
NTCELL to be produced in Australia under UTS research agreement
Government launches biotechnology – strategic plan for health and medicine
Dimerix receives R&D tax rebate for last financial year
Neuren receives FDA approval for Pitt Hopkins IND and Phase 2 trial
BioScience Managers welcomes FDA approval of Saluda technology
Large molecule facility doubles size of leading bioanalytical laboratory
Industry concerned by leaked Covid vaccine IP waiver text
Biotron updates on pre-clinical study of BIT225 in Covid
US FDA grants new orphan designation to Noxopharm’s Veyonda
Access savings by registering early for AusMedtech 2022
Paradigm secures UK approvals for PARA_OA_002 clinical trial
First Participants dosed in ENA Respiratory’s phase 2a study